Items of recent pandemic news: Boosters approved for kids 5-11; the cause of severe Covid-19; two new vaccines built on different technology bases; immune evasiveness of two Omicron sub-variants; Paxlovid developments; and much more. Plus a frippery. The pandemic sputters … Continue reading →
This newsletter is tapering down. For 25 months I have been documenting the medical and scientific history of this extraordinary time. The country now acts as if it is over; what urgency the pandemic still commanded is leaching out. Herewith … Continue reading →
Items of recent pandemic news: Moderna announces preliminary results for their vaccine in children; the White House rolls out the one-stop information site covid.gov; FDA authorizes a fourth shot for older adults; and much more. Plus a frippery. Apologies to … Continue reading →
This week marks two years since the WHO declared a pandemic. As the Omicron wave recedes, here are some longer-form perspectives on where we are headed and where we should perhaps be headed instead. Plus a Ukrainian frippery. Quote of … Continue reading →
Items of recent pandemic news: A new, wildly divergent SARS-CoV-2 strain in deer; mental health sequelae in Covid-19 survivors; an update on locating a supply of Paxlovid; new CDC masking guidance; and more. Plus a Ukrainian frippery. Quote of the … Continue reading →
Items of recent pandemic news: The criticality of public trust to public health; how history says the pandemic will end; two promising, broad-spectrum inhalable vaccines in development; and the state of the BA.2 Omicron sub-variant. Plus a frippery. Quote of … Continue reading →
Items of recent pandemic news: Antihistamines may help some long Covid; J&J pauses manufacturing vaccine; FDA authorizes Eli Lilly’s injectable monoclonal; how boosters wane; and a further delay in shots for the youngest children. Plus a frippery. Quote of the … Continue reading →
Items of recent pandemic news: Omicron boosters prove unhelpful; wastewater surveillance comes into its own; Covid-19 causes long-term heart and circulatory issues; results from the first SARS-CoV-2 challenge trial published; and more. Plus two fripperies. Quote of the week Eric … Continue reading →
Items of recent pandemic news: Cryptic Covid lineages in NYC wastewater; a possible stall in Omicron’s nationwide decline; Novavax files for EUA and Moderna is approved; and authorized vaccines for the youngest kids, within a few weeks. Plus a frippery. … Continue reading →
Items of recent pandemic news: Historical perspective and promising research on long Covid; beginning Omicron-targeted vaccine trials; press attention for a new CBD study; Hong Kong’s zero-Covid strategy and Omicron; and BA.2 in the US. Plus a frippery. Quotes of … Continue reading →
Items of recent pandemic news: A resource for finding authorized therapeutics in the US; how long booster shots protect; an early study isolating ultrapotent antibodies from elite neutralizers; and a new variant on the Omicron variant. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: After-effects of a saline shot; a genetic correlate to the Covid-19 loss of smell & taste; international coordination for deciding on targeted boosters; and the administration’s program of free rapid tests. Plus a frippery. Quote … Continue reading →
Items of recent pandemic news: Compounds found in hemp slow viral growth in the lab; the durability of SARS-CoV-2 in air; the virus’s danger to unvaxed pregnant people; and striking down federal workplace mandates. Plus a pair of fripperies. Quote … Continue reading →
Items of recent pandemic news: The data on incidental Covid; where the Omicron wave may go and when; months-long persistence of the virus in multiple organ systems; and an entreaty to the President to think endemic. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Monitoring sewage for Covid early warning; therapeutics in short supply; a variant of little concern; antigen tests may miss early infectivity; Pfizer boost authorized for 12-15-year-olds; and more. Plus a frippery. Quote of the week … Continue reading →
